Panax Ginseng لـ Age-Related Cognitive Decline

Multiple RCTs with mixed but generally positive results for cognitive function. Evidence is not yet convincing for dementia prevention, but acute cognitive enhancement effects are supported by several trials.

𝕏 LinkedIn

<\/script>\n

`; }, get iframeSnippet() { const domain = 'braincited.com'; const params = 'ingredient\u003Dpanax\u002Dginseng\u0026condition\u003Dcognitive\u002Ddecline'; return ``; }, get activeSnippet() { return this.method === 'script' ? this.scriptSnippet : this.iframeSnippet; }, copySnippet() { navigator.clipboard.writeText(this.activeSnippet).then(() => { this.copied = true; setTimeout(() => { this.copied = false; }, 2000); }); } }" @keydown.escape.window="open = false" @click.outside="open = false">

Embed This Widget

Style

Widget powered by . Free, no account required.

الخلاصة

Key Study Findings

Animal study

Ginsenoside Rg1 alleviates PCPA-induced insomnia by inhibiting NLRP3 inflammasome activation and pyroptosis through the Nrf2/HO-1 …

Dose: None مقابل: Placebo التأثير: None None

Review

Advanced nutraceutical approaches to Parkinson's disease: bridging nutrition and neuroprotection.

Dose: None مقابل: None Outcome: None التأثير: None None

المجتمع المدروس: None

Review

Review of Pharmacotherapeutic Targets in Alzheimer's Disease and Its Management Using Traditional Medicinal Plants.

Dose: None مقابل: None Outcome: AD pharmacotherapeutic target modulation التأثير: None None

المجتمع المدروس: Alzheimer's disease patients (review)

Review

The effects of twenty-one nutrients and phytonutrients on cognitive function: A narrative review.

Dose: None مقابل: None Outcome: None التأثير: None None

المجتمع المدروس: None

Systematic Review

Dietary Supplement Ingredients for Optimizing Cognitive Performance Among Healthy Adults: A Systematic Review.

Dose: None مقابل: placebo Outcome: None التأثير: None None

المجتمع المدروس: healthy adults

Other

Protocols for cognitive enhancement. A user manual for Brain Health Services-part 5 of 6.

Dose: None مقابل: None Outcome: None التأثير: None None

المجتمع المدروس: None

Key Statistics

الدراسات

1500

المشاركون

↔

Mixed

التقييم

Referenced Papers

Advanced nutraceutical approaches to Parkinson's disease: bridging nutrition and neuroprotection. Review

Nutritional neuroscience 2025 14 اقتباسات

Ginsenoside Rg1 alleviates PCPA-induced insomnia by inhibiting NLRP3 inflammasome activation and pyroptosis through the Nrf2/HO-1 pathway in mice. Other

Psychopharmacology 2025 5 اقتباسات

Review of Pharmacotherapeutic Targets in Alzheimer's Disease and Its Management Using Traditional Medicinal Plants. Review

Degenerative neurological and … 2024 66 اقتباسات

The effects of twenty-one nutrients and phytonutrients on cognitive function: A narrative review. Review

Journal of clinical … 2021 38 اقتباسات

Dietary Supplement Ingredients for Optimizing Cognitive Performance Among Healthy Adults: A Systematic Review. Systematic Review

Journal of alternative … 2021 13 اقتباسات

Protocols for cognitive enhancement. A user manual for Brain Health Services-part 5 of 6. Other

Alzheimer's research & … 2021 1 اقتباسات

Dosage & Usage

mg = milligrams · mcg = micrograms (1,000× smaller) · IU = International Units

الجرعات الشائعة

general:: 200-400 mg/day standardized to 4-7% ginsenosides

الحد الأعلى: Not established; up to 3,000 mg/day used short-term

الجرعات المدروسة في الأبحاث

الجرعة	المدة	التأثير	ن
None	--	Positive	--
None	--	Mixed	--
None	--	Positive	--
None	--	Mixed	--
None	--	Positive	--
None	--	Positive	--

أفضل وقت للتناول: Morning; cycling recommended (8 weeks on, 2 weeks off)

Safety & Side Effects

الآثار الجانبية المُبلّغ عنها

⚠ Insomnia
⚠ Headache
⚠ Gastrointestinal discomfort
⚠ Changes in blood pressure
⚠ Rare: hypoglycemia

التفاعلات المعروفة

● Anticoagulants and antiplatelet drugs
● Antidiabetic drugs (may lower blood sugar)
● MAO inhibitors (may potentiate effects)
● Stimulants (additive stimulatory effects)

الحد الأقصى المسموح به: Not established; up to 3,000 mg/day used short-term

استشر مقدم الرعاية الصحية دائماً قبل البدء بأي مكمل غذائي.

Frequently Asked Questions

Does Panax Ginseng help with Age-Related Cognitive Decline?

Based on 15 studies with 1,500 participants, there is limited but promising evidence that Panax Ginseng may support Age-Related Cognitive Decline management. Our evidence grade is C (Some Evidence).

How much Panax Ginseng should I take for Age-Related Cognitive Decline?

Studies have used various dosages. A commonly studied range is 200-400 mg/day standardized to 4-7% ginsenosides. Always consult your healthcare provider before starting any supplement regimen.

Are there side effects of Panax Ginseng?

Reported side effects may include Insomnia, Headache, Gastrointestinal discomfort, Changes in blood pressure. Most side effects are mild and dose-dependent. Consult your doctor if you experience any adverse reactions.

How strong is the evidence for Panax Ginseng and Age-Related Cognitive Decline?

We rate the evidence as Grade C (Some Evidence). This rating is based on 15 peer-reviewed studies with 1,500 total participants. The overall direction of effect is mixed.

Related Evidence

مكونات أخرى لـ Age-Related Cognitive Decline

Omega-3 Fatty Acids (DHA/EPA) A Phosphatidylserine B Bacopa monnieri B Vitamin B12 B Curcumin B Ginkgo biloba C

Panax Ginseng لحالات أخرى

Mental Fatigue C

الخلاصة السريعة

Evidence Strength52%

Moderate confidence

تفصيل الدراسات

RCT (0)Meta (0)Other (15)

قارن البدائل

اعرف كيف تقارن المكونات الأخرى لهذه الحالة.

عرض جميع المكونات لـ Age-Related Cognitive Decline

اعرف المزيد

إخلاء مسؤولية FDA: لم تُقيَّم هذه البيانات من قبل إدارة الغذاء والدواء (FDA). لا تهدف المنتجات والمعلومات الواردة في هذا الموقع إلى تشخيص أو علاج أو شفاء أو الوقاية من أي مرض. تستند تقييمات الأدلة المعروضة إلى تحليلنا للأبحاث المحكّمة المنشورة ولا تُشكّل نصيحة طبية. استشر مقدم الرعاية الصحية دائماً قبل البدء بأي نظام مكملات.